Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
1.861
+0.001 (0.06%)
Aug 7, 2026, 12:44 PM EDT - Market open
Annovis Bio Market Cap
Annovis Bio has a market cap or net worth of $79.17 million as of August 7, 2026. Its market cap has increased by 52.18% in one year.
Market Cap
79.17M
Enterprise Value
64.96M
1-Year Change
52.18%
Ranking
Category
Stock Price
$1.86
ChartMarket Cap Chart
Since January 29, 2020, Annovis Bio's market cap has increased from $62.51M to $79.17M, an increase of 26.66%. That is a compound annual growth rate of 3.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 79.17M | -13.66% |
| Dec 31, 2025 | 91.70M | 32.13% |
| Dec 31, 2024 | 69.40M | -63.84% |
| Dec 29, 2023 | 191.90M | 75.03% |
| Dec 30, 2022 | 109.64M | -23.01% |
| Dec 31, 2021 | 142.41M | 174.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PolyPid | 85.32M |
| Alterity Therapeutics | 85.24M |
| Rallybio | 84.56M |
| MAIA Biotechnology | 82.69M |
| Telomir Pharmaceuticals | 79.09M |
| Atara Biotherapeutics | 79.02M |
| Champions Oncology | 75.72M |
| Gain Therapeutics | 75.07M |